Desafios terapêuticos da mucosite oral em oncopediatria / Therapeutic challenges of oral mucositis in pediatric oncology

O Neuroblastoma (NB) é uma neoplasia do sistema nervoso simpático, e o segundo tumor sólido maligno extracraniano mais comum da infância. Na terapia antineoplásica, complicações orais podem ser observadas, dentre elas a mucosite oral (MO). Trata-se de uma inflamação aguda da mucosa, proveniente da toxicidade dos quimioterápicos. Este relato de caso enfatiza o manejo da MO, bem como sua influência na condição sistêmica e qualidade de vida. Paciente do sexo feminino, nove anos, apresentou recidiva de NB metastático, após tratamento de primeira linha. Admitida na unidade hospitalar para tratamento oncológico na enfermaria de pediatria oncológica, queixando-se de dor intensa em cavidade bucal e orofaringe, associada a pancitopenia severa febril. Ao exame físico apresentava disfagia e déficit ponderal grave, que debilitava a deglutição da própria saliva. O exame intraoral revelou lesões de MO grau 3, segundo a Organização Mundial de Saúde (OMS), em lábios, gengiva anterior e orofaringe. O tratamento consistiu em remoção de debris local, higiene da cavidade bucal com clorexidina 0,12% e utilizando haste flexível de algodão estéril tipo "Swab", visando controle microbiano local, diariamente. Além disso, foi aplicado no leito eritematoso e hemorrágico fotobiomodulação (660 nm, 50 mW, 2 J/cm2, 90 segundos) pontualmente nas áreas do leito da lesão e em varredura na região de orofaringe (sessões intercaladas). Foi prescrito acetato de racealfatocoferol (vitamina E) para ação antioxidante e hidratação dos lábios. Concomitante a mucosite, a paciente apresentou pancitopenia febril severa, sendo necessário uso de cefepima 150 mg/kg/dia, com coleta prévia de hemoculturas, fator estimulador de colônias de granulócitos, Fluconazol, hidratação e suporte nutricional. As hemoculturas foram negativas. As consequências da mucosite contribuíram para desnutrição e piora da qualidade de vida. Conclui-se que a intervenção odontológica em interdisciplinaridade, possibilitou o restabelecimento físico e emocional, possibilitando melhor uma qualidade de vida da paciente (AU).

Neuroblastoma (NB) is a neoplasia of the sympathetic nervous system and the second most common extracranial malignant solid tumor in childhood. In antineoplastic therapy, oral complications can be observed in antineoplastic therapy, among them oral mucositis (OM). It is an acute mucosa inflammation resulting from the toxicity of chemotherapy drugs. This case report emphasizes the management of OM and its influence on the systemic condition and quality of life. A female patient, nine years old, presented a recurrence of metastatic NB after first-line treatment. She was admitted to the hospital unit for oncological therapy in the pediatric oncology ward, complaining of severe pain in the oral cavity and oropharynx associated with severe febrile pancytopenia. On physical examination, she presented dysphagia and severe weight deficit, which weakened the swallowing of her saliva. According to the World Health Organization (WHO), the intraoral exam revealed third-grade OM lesions on the lips, anterior gum, and oropharynx. Treatment consisted of removing local debris, cleaning the oral cavity with 0.12% chlorhexidine, and using a flexible, sterile cotton swab, aiming for daily local microbial control. In addition, photobiomodulation (660 nm, 50 mW, 2 J/cm2, 90 seconds) was applied to the erythematous and hemorrhagic bed, punctually in the areas of the lesion and sweeps in the oropharynx region (interspersed sessions). Racealphatocopherol acetate (vitamin E) was prescribed for antioxidant action and lip hydration. Concomitant with mucositis, the patient had severe febrile pancytopenia, requiring cefepime 150 mg/kg/day, with previous collection of blood cultures, granulocyte colony-stimulating factor, fluconazole, hydration, and nutritional support. Blood cultures were negative. The consequences of mucositis contributed to malnutrition and worsened quality of life. It is concluded that the interdisciplinary dental intervention enabled physical and emotional restoration, enabling a better quality of life for the patient (AU).

Dental intervention prior to and subsequent to the diagnosis of acute myeloid leukemia: case report / Intervenção odontológica prévia e subsequente ao diagnóstico de leucemia mielóide aguda: relato de caso

ABSTRACT Leukemia's are characterized by the proliferation of immature white blood cells, called blasts, in the bone marrow and / or blood. Among them, we highlight the Monocytic Acute Myeloid Leukemia, which represents a malignant neoplasm whose unnatural monoblast proliferation results in suppression of myeloid series cells. Oral manifestations are common, arising at the onset of the disease and are also associated with chemotherapy during treatment leading to complications that compromise oncotherapy. The present study deals with a patient with this type of aggressive leukemia, with oral complications of the disease and later, oncological treatment. It also give prominence the performance of the dental surgeon in distinct phases of the treatment emphasizing the importance of maintaining oral health in cancer patients. The presence of the Dentist in the multi-professional team contributes to the reduction of manifestations that occur both due to the disease and the treatment, ensuring a better quality of life for cancer patients and avoiding higher expenses to the health system.

RESUMO As leucemias são caracterizadas pela proliferação de células imaturas da linhagem branca, denominadas blastos, na medula óssea e/ou sangue. Dentre elas destacamos a Leucemia Mielóide Aguda Monocítica, que representa uma neoplasia maligna, cuja proliferação anormal de monoblastos resulta na supressão das células da série mielóide. Manifestações orais são comuns, surgindo no início da doença e também associadas à quimioterapia durante o tratamento gerando complicações que comprometem a oncoterapia. O presente trabalho trata-se de um paciente portador deste tipo agressivo de leucemia, com complicações bucais da doença e posteriormente, do tratamento oncológico. Destaca ainda a atuação do cirurgião-dentista em fases distintas do tratamento realçando a importância da manutenção da saúde bucal em pacientes oncológicos. A presença do Cirurgião-Dentista na equipe multiprofissional contribui para diminuição das manifestações que ocorrem tanto devido à doença quanto ao tratamento, garantindo melhor qualidade de vida do paciente oncológico e evitando maiores gastos ao sistema de saúde.

Inserção da Odontologia Hospitalar na grade curricular dos cursos de Odontologia do sudeste brasileiro / Insertion of Hospital Dentistry in the curricular grade of the southeast brazilian Dentistry courses

Objetivo: Avaliar a inserção da Odontologia Hospitalar nos Projetos Políticos Pedagógicos dos cursos de Odontologia das Instituições de Ensino Superior da Região Sudeste do Brasil. Materiais e Métodos: Realizou-se um estudo transversal e quantitativo, na qual as grades curriculares dos cursos foram analisadas, buscando-se as informações referentes às variáveis: inserção da disciplina, categoria administrativa da instituição, natureza do componente curricular, metodologia de ensino, período de oferta e carga horária. Os dados foram tabulados utilizando o programa GraphPad Prism 8.1.2, sendo analisados por meio de esta-tísticas descritivas. Resultados: Dentre as 176 universidades encontradas, 144 foram avaliadas e incluídas no estudo. Verificou-se que 46 instituições (31,9%) apresentavam a disciplina de Odontologia Hospitalar, sendo que destas, 38 (82,6%) possuem caráter obrigatório. Em relação à meto-dologia de ensino empregada, 21 (45,6%) possuem natureza apenas prática, 10 (21,7%) teórico-prática, 9 (19,5%) apenas teórica e 6 (13,6%) não especificaram a metodologia. A análise da carga horária reservada para a disciplina apresentou uma média de 73,83 horas, sendo a máxima de 176 horas e a mínima de 30 horas. Conclusão: A Odontologia Hospitalar como componente curricular nos cursos de Odontologia exibe-se ainda de maneira bastante discreta. Como o Projeto Político Pedagógico está em constante elaboração e deve acompanhar as transformações e exigências profissionais, estes dados alertam para necessidade de estruturação de diretrizes para consolidação desta área de conhecimento na formação do cirurgião-dentista.

Objective: Evaluate the insertion of Hospital Dentistry in the Pedagogical Political Projects of the Dentistry courses of Higher Education Institution in the Southeast of Brazil. Materials and Methods: A cross-sectional and quantitative study was carried out, in which the curri-cula of the courses were analyzed, seeking information regarding the variables: insertion of the discipline, admi-nistrative category of institution, nature of the curricular component, teaching methodology, period of study and workload. Data were tabulated using GraphPad Prism 8.1.2 software and analyzed using descriptive statistics. Results: 176 universities found, 144 were evaluated and included in the study. It was found that 46 institutions (31.9%) had the discipline of Hospital Dentistry, and 38 (82.6%) are compulsory. Regarding the teaching metho-dology employed, 21 (45.6%) are only practical, 10 (21.7%) theoretical-practical, 9 (19.5%) only theoretical and 6 (13.6%) did not specify the methodology. The analysis of the workload reserved for the course presented an ave-rage of 73.83 hours, with a maximum of 176 hours and a minimum of 30 hours. Conclusion: Hospital Dentistry is a very discrete curricular component in Dentistry courses. As the Pedagogical Political Projects is in constant ela-boration and must follow the changes and professional demands, these data alert to the need for structuring guidelines for consolidation of this area of knowledge in the formation of the dentist.

Endocarditis Caused by Gram-Negative Moraxella osloensis in an Immunocompetent Patient: First Case Report in Latin America.

This is a case report of infective endocarditis due to Moraxella osloensis. This study would be the fourth since the two latest episodes were described in 2015. The patient of this exposition is different from those previously described in the literature because it was a young adult, under 50 years of age, immunocompetent, with no comorbidities and no obvious focus of infection.

Delivering Resveratrol on the Buccal Mucosa Using Mucoadhesive Tablets: A Potential Treatment Strategy for Inflammatory Oral Lesions.

BACKGROUND: Resveratrol is a polyphenol that has gained momentum in therapeutics in the last few years. OBJECTIVE: In this study, we hypothesised that resveratrol could act prophylactically and/or treat inflammatory lesions of the oral cavity after being delivered by two different formulations of buccal mucoadhesive tablets (F1 and F2, which differed in terms of viscosity agents used). METHODS: This hypothesis was assessed through permeation studies, to verify diffusion of the drug through the buccal mucosa using a porcine model to predict human in vivo behaviour. RESULTS: F2 (tablet with less viscosity agent) presented better permeation than F1, but the amount of drug that crossed the mucosa was still low compared to the amount retained within it (35.90 µg found in the receptor medium and 15.63 mg quantified within the mucosa). CONCLUSION: This accounted for a local effect rather than a systemic one, which is desirable for local processes, such as oral mucositis, lichen planus, erythema multiforme, nicotinic stomatitis, recurrent aphthous stomatitis, among others. In this sense, resveratrol-loaded mucoadhesive tablets appear to be a prominent alternative to prevent and/or cure inflammatory lesions of the oral cavity.

Oral warning signs of elastic pseudoxanthoma.

The pseudoxanthoma elasticum is a multisystemic heritable disease that primarily affects the connective tissue. It has been characterized by fragmentation and calcification of elastic fibers that can lead to complications of skin and cardiovascular system and changes in retina. Involvement of the oral mucosa has been described like white patches striated especially in the mucosa of both upper and lower lips. These oral signs are potentially useful to diagnose the disease, since it is an often undiagnosed disease due to the variability in phenotypic expressions. This study reports a case of pseudoxanthoma elasticum affecting a woman who developed lesions in the oral mucosa during the disease progression. Intraoral clinical assessment revealed the presence of changes mainly in lower labial mucosa and also slightly changes in the mouth floor and the upper labial mucosa. Therefore, the acknowledgment of oral pseudoxanthoma elasticum lesions helps dental practitioners to establish an early and appropriate diagnosis of this disease. This is very important because pseudoxanthoma elasticum is a multisystem disease with morbidity and mortality, and its early diagnosis and also the establishment of a follow-up protocol for these patients could prevent systemic and oral complications.

Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.

BACKGROUND: Oral infections are prevalent in the adult population. Their impact includes the implication as a risk factor for Alzheimer's disease (AD), altering its progression. One of the potential mechanisms involves immune mediators such as circulating cytokines. OBJECTIVE: The goal of the present study was to investigate the prevalence of oral infections and blood levels of IL-1ß, TNF-α, and IL-6 in patients with AD, mild cognitive impairment (MCI), and controls. METHODS: Sixty-five elderly were evaluated (25 AD, 19 MCI, and 21 controls) by the following methods: Mini Mental State Exam, Questionnaire of Functional Activities, periodontal and oral evaluation, and blood concentrations of IL-1ß, TNF-α and IL-6. RESULTS: Patients with AD had high serum IL-6 levels (p = 0.029), and patients with periodontitis had high serum TNF-α levels (p = 0.005). There was an association between IL-6 and TNF-α in patients with AD/MCI and periodontitis (p = 0.023). CONCLUSION: The increased levels of TNF-α and IL-6 in this study suggests their implication in the overlapping mechanisms between oral infections and AD. Longitudinal studies are necessary for further investigation.

Evaluation of patients with Alzheimer's disease before and after dental treatment.

Oral infections may play a role in Alzheimer's disease (AD). Objective To describe the orofacial pain, dental characteristics and associated factors in patients with Alzheimer's Disease that underwent dental treatment. Method 29 patients with mild AD diagnosed by a neurologist were included. They fulfilled the Mini Mental State Exam and Pfeffer's questionnaire. A dentist performed a complete evaluation: clinical questionnaire; research diagnostic criteria for temporomandibular disorders; McGill pain questionnaire; oral health impact profile; decayed, missing and filled teeth index; and complete periodontal investigation. The protocol was applied before and after the dental treatment. Periodontal treatments (scaling), extractions and topic nystatin were the most frequent. Results There was a reduction in pain frequency (p=0.014), mandibular functional limitations (p=0.011) and periodontal indexes (p<0.05), and an improvement in quality of life (p=0.009) and functional impairment due to cognitive compromise (p<0.001) after the dental treatment. Orofacial complaints and intensity of pain also diminished. Conclusion The dental treatment contributed to reduce co-morbidities associated with AD and should be routinely included in the assessment of these patients.

Evaluation of patients with Alzheimer's disease before and after dental treatment / Avaliação de pacientes com doença de Alzheimer antes e depois do tratamento dentário

Oral infections may play a role in Alzheimer's disease (AD). Objective To describe the orofacial pain, dental characteristics and associated factors in patients with Alzheimer's Disease that underwent dental treatment. Method 29 patients with mild AD diagnosed by a neurologist were included. They fulfilled the Mini Mental State Exam and Pfeffer's questionnaire. A dentist performed a complete evaluation: clinical questionnaire; research diagnostic criteria for temporomandibular disorders; McGill pain questionnaire; oral health impact profile; decayed, missing and filled teeth index; and complete periodontal investigation. The protocol was applied before and after the dental treatment. Periodontal treatments (scaling), extractions and topic nystatin were the most frequent. Results There was a reduction in pain frequency (p=0.014), mandibular functional limitations (p=0.011) and periodontal indexes (p<0.05), and an improvement in quality of life (p=0.009) and functional impairment due to cognitive compromise (p<0.001) after the dental treatment. Orofacial complaints and intensity of pain also diminished. Conclusion The dental treatment contributed to reduce co-morbidities associated with AD and should be routinely included in the assessment of these patients. .

Infecções orais podem ter um papel na doença de Alzheimer (DA). Objetivo Descrever as características orofaciais, dor, odontológicas e fatores associados em doentes com DA submetidos a tratamento dentário. Método 29 doentes diagnosticados com DA por neurologista foram avaliados através do Mini Exame do Estado Mental e questionário Pfeffer. O exame odontológico foi realizado antes e depois do tratamento dentário e incluiu: questionário clínico; critérios diagnósticos de pesquisa para disfunção temporomandibular; questionário de dor McGill; protocolo de impacto de saúde oral; dentes cariados, perdidos e obturados; e avaliação periodontal. Os procedimentos mais frequentes foram raspagem periodontal, exodontias e prescrição de nistatina tópica. Resultados Houve uma redução na frequência de dor (p=0,014), limitações mandibulares (p=0,011), índices periodontais (p<0.05), e melhora na qualidade de vida (p=0,009) e no comprometimento funcional e cognitivo (p<0,001) após o tratamento dentário. Queixas orofaciais e intensidade de dor também diminuíram. Conclusão O tratamento dentário contribuiu para reduzir comorbidades associadas à DA e deveria ser incluído na rotina de avaliação desses pacientes. .

Periodontitis and Metabolic Control: A Preliminary Study / Periodontitis y Control Metabólico: Estudio Preliminar

The aim of this study was to evaluate the periodontal condition and the metabolic control of patients with diabetes mellitus type 2. Patients with diabetes mellitus type 2 were evaluated pre- and post (30 days) treatment of the periodontitis through the following exams: glycemia, glycosylated hemoglobin, plaque index, gingival bleeding index and periodontal pocket depth index. Periodontal treatment consisted of: Scaling, root planning and plaque control, associated with systemic antibiotic therapy with amoxicillin. Seventeen patients (12 women and 5 men; mean age = 55.94 years) were included. The chief complaints were: gingival bleeding (n=13); gingival pain (n=8), tooth mobility (n=3), gingival swelling (n=2) and halitosis (n=2). The mean time of these complaints ranged from 2 months to 20 years. None of them had ever received guidance on oral hygiene or dental assessment. There was a reduction in the following indexes (30 days after the periodontal treatment): plaque, from 41.79±24% to 12.26±13%) (p0.0005), gingival bleeding from 51.58±25%) to 15.77±15% (p0.0005), periodontal pocket depth from 0.98±0.91 mm to 1.76±0.63 mm) (p0.0005). In 15 patients there was a reduction in the glycosylated hemoglobin (10.85±3.03% to 8.72±1.68%) (p0.0005). This preliminary study shows that patients of this sample had chronic and severe periodontal disease; there was a reduction in the glycosylated hemoglobin levels, but not of glycemia, 30 days after periodontal treatment. Long-standing studies are necessary; however patients with diabetes mellitus need control of chronic infections, including periodontal disease.

El objetivo fue evaluar la condición periodontal y el control metabólico de pacientes con diabetes mellitus tipo 2. En los pacientes con diabetes mellitus tipo 2 se evaluaron previo y posterior (30 días) al tratamiento de la periodontitis los siguientes exámenes: glucemia, hemoglobina glicosilada, índice de placa bacteriana, índice de sangrado gingival e índice de profundidad de la bolsa periodontal. El tratamiento periodontal consistió en: curetage, alisado radicular y control de placa, asociado a la terapia sistémica antibiótica con amoxicilina. Se evaluaron 17 pacientes (12 mujeres y 5 hombres, con una edad media de 55,94 años). Las principales complicaciones fueron: sangrado gingival (n= 13), dolor gingival (n= 8), movilidad dental (n= 3), edema gingival (n= 2) y halitosis (n= 2). El tiempo medio de estas complicaciones varió entre 2 meses y 20 años. Ninguno de ellos reconoció haber recibido orientación sobre higiene oral o evaluación dental. Hubo una reducción (30 días después del tratamiento periodontal) en los siguientes índices: placa, de 41,79±24% a 12,26±13%) (p0,0005); sangrado gingival, de 51,58±25%) a 15,77±15% (p0,0005), profundidad de la bolsa periodontal, de 0,98±0,91 mm a 1,76±0,63 mm) (p0,0005). En 15 pacientes se observó una reducción en la hemoglobina glucosilada (10,85±3,03% a 8,72±1,68%) (p0,0005). Observamos que los pacientes de esta muestra tenían enfermedad periodontal crónica y severa; que hubo una reducción en los niveles de hemoglobina glucosilada, pero no de la glucemia, 30 días después del tratamiento periodontal. Estudios longitudinales son necesarias, sin embargo los pacientes con diabetes mellitus requieren control de las infecciones crónicas, como la enfermedad periodontal.

Oral infections and orofacial pain in Alzheimer's disease: a case-control study.

BACKGROUND: Dental infections are frequent and have recently been implicated as a possible risk factor for Alzheimer's disease (AD). Despite a lack of studies investigating orofacial pain in this patient group, dental conditions are known to be a potential cause of pain and to affect quality of life and disease progression. OBJECTIVES: To evaluate oral status, mandibular function and orofacial pain in patients with mild AD versus healthy subjects matched for age and gender. METHODS: Twenty-nine patients and 30 control subjects were evaluated. The protocol comprised a clinical questionnaire and dental exam, research diagnostic criteria for temporomandibular disorders, the McGill Pain Questionnaire, the decayed, missing, and filled teeth index, and included a full periodontal evaluation. AD signs and symptoms as well as associated factors were evaluated by a trained neurologist. RESULTS: A higher prevalence of orofacial pain (20.7%, p < 0.001), articular abnormalities in temporomandibular joints (p < 0.05), and periodontal infections (p = 0.002) was observed in the study group compared to the control group. CONCLUSION: Orofacial pain and periodontal infections were more frequent in patients with mild AD than in healthy subjects. Orofacial pain screening and dental and oral exams should be routinely performed in AD patients in order to identify pathological conditions that need treatment thus improving quality of life compromised due to dementia.

Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.

OBJECTIVE: This study aimed to evaluate prospectively the influence and the evolution of periodontal disease (PD) in rheumatoid arthritis (RA) patients submitted to anti-tumor necrosis factor (TNF) therapy. METHODS: Eighteen patients with RA (according to the American College of Rheumatology criteria) were assessed for PD before (BL) and after 6 months (6M) of anti-TNF treatment: 15 infliximab, 2 adalimumab, and 1 etanercept. Periodontal assessment included plaque and gingival bleeding indices, probing pocket depth, cementoenamel junction, and clinical attachment level. Rheumatologic evaluation was performed blinded to the dentist's assessment: demographic data, clinical manifestations, and disease activity (Disease Activity Score using 28 joints [DAS28], erythrocyte sedimentation rate [ESR], and C-reactive protein [CRP]). RESULTS: The median age and disease duration of patients with RA were 50 years (25-71 y) and 94% were female. Periodontal disease was diagnosed in 8 patients (44.4%). Comparing BL to 6M, periodontal parameters in the entire group remained stable (P > 0.05) throughout the study (plaque and gingival bleeding indices, probing pocket depth, cementoenamel junction, and clinical attachment level), whereas an improvement in most analyzed RA parameters was observed in the same period: DAS28 (5.5 vs. 3.9, P = 0.02), ESR (21 vs. 12.5 mm/first hour, P = 0.07), and CRP (7.8 vs. 2.8 mg/dL, P = 0.25). Further analysis revealed that this improvement was restricted to the group of patients without PD (DAS28 [5.5 vs. 3.6, P = 0.04], ESR [23.0 vs. 11.5 mm/first hour, P = 0.008], and CRP [7.4 vs. 2.1, P = 0.01]). In contrast, patients with PD had lack of response, with no significant differences in disease activity parameters between BL and 6M: DAS28 (5.2 vs. 4.4, P = 0.11), ESR (17.0 vs. 21.0, P = 0.56), and CRP (9.0 vs. 8.8, P = 0.55). CONCLUSIONS: This study supports the notion that PD may affect TNF blocker efficacy in patients with RA. The possibility that a sustained gingival inflammatory state may hamper treatment response in this disease has high clinical interest because this is a treatable condition.

Refractory craniofacial pain: is there a role of periodontal disease as a comorbidity?

OBJECTIVE: To evaluate the influence of the periodontal disease (PD), a chronic infection, in patients with chronic craniofacial pain complaints. METHOD: Twenty patients with chronic craniofacial pain and PD (CFP group) and 20 patients with PD (PD group) were assessed before and after periodontal treatment (baseline, 30 and 180 days after treatment). The parameters evaluated were: plaque index, bleeding index, clinical probe insertion, Visual Analogic Scale (VAS) for pain intensity and Numerical Rating Scale (NRS) and Verbal Rating Scale (VRS) for the 'chief complaint'. RESULTS: After 180 days PD was controlled in both groups (p<0.001); the VAS decreased in CFP group (p<0.001); 'chief complaint' improved (p=0.005 and p=0.027, respectively in CFP and PD group). VRS showed improvement between the groups in 30 (p=0.004) and 180 days (p=0.001). CONCLUSION: These results suggest a possible influence of periodontal disease, as a comorbidity, in refractory craniofacial pain patients and in their pain levels.

Refractory craniofacial pain: is there a role of periodontal disease as a comorbidity? / Dor refratária crânio-facial: há algum papel para a doença periodontal como morbidade associada?

OBJETIVE: To evaluate the influence of the periodontal disease (PD), a chronic infection, in patients with chronic craniofacial pain complaints. METHOD: Twenty patients with chronic craniofacial pain and PD (CFP group) and 20 patients with PD (PD group) were assessed before and after periodontal treatment (baseline, 30 and 180 days after treatment). The paramenters evaluated were: plaque index, bleeding index, clinical probe insertion, Visual Analogic Scale (VAS) for pain intensity and Numerical Rating Scale (NRS) and Verbal Rating Scale (VRS) for the "chief complaint". RESULTS: After 180 days PD was controlled in both groups (p<0.001); the VAS decreased in CFP group (p<0.001); "chief complaint" improved (p=0.005 and p=0.027, respectively in CFP and PD group). VRS showed improvement between the groups in 30 (p=0.004) and 180 days (p=0.001). CONCLUSION: These results suggest a possible influence of periodontal disease, as a comorbidity, in refractory craniofacial pain patients and in their pain levels.

OBJETIVO: Avaliar a influência da doença periodontal (DP) em pacientes com queixas de dores crônicas crânio-faciais. MÉTODO: Vinte pacientes com dor crônica crânio-facial e DP (CFP group) e 20 pacientes com DP (PD group) foram avaliados antes e depois do tratamento periodontal (baseline, 30 e 180 dias). Avaliações: índice de placa, índice de sangramento gingival, inserção clínica de bolsa, Escala Visual Analógica (VAS) para a dor, Escalas Numérica (NRS) e Verbal (VRS) para as "queixas principais". RESULTADOS: Após 180 dias a DP foi controlada em ambos os grupos (p<0,001); a VAS reduziu no CFP group (p<0,001); a "queixa principal" melhorou (p=0,005 e p=0,027, respectivamente nos grupos CFP e PD). A VRS mostrou diferença entre os grupos em 30 (p=0,004) e 180 dias (p=0,001). CONCLUSÕES: Estes resultados sugerem a provável influência da doença periodontal, como morbidade associada, nos níveis de dor de pacientes com dores crônicas crânio-faciais.

Doença periodontal grave em pacientes com e sem queixa de dor crônica crânio-facial: correlação dos aspectos clínicos com a análise quantitativa da substância P e do óxido nítrico do tecido gengival inflamado / Severe periodontal disease in patients with and without chronic complaint of cranium-facial pain: correlation of clinical aspects with the quantitative analysis of substance P and nitric oxide of inflamed gingival tissue

Com o objetivo de avaliar a implicação da doença periodontal avançada (DP), e da expressão da NOS e sP dos tecidos gengivais inflamados, na intensidade de dor e na qualidade de vida de pacientes com dor crônica crânio-facial; foram avaliados e tratados 20 pacientes com queixas de dor crônica crânio-facial e DP (Grupo de Estudo), comparativamente com 20 pacientes que tinham somente DP (Grupo Controle). Após o tratamento periodontal houve redução da EVA no Grupo de Estudo e houve melhora significativa das queixas iniciais. No Grupo de Estudo, houve redução dos descritores afetivos de dor e os escores de qualidade de vida foram inferiores aos do Grupo Controle nos domínios psicológico e físico. As expressões da nNOS e da iNOS foram maiores nas gengivas inflamadas do Grupo de Estudo e a expressão da sP foi semelhante nos dois grupos. Pelos dados deste estudo a Doença Periodontal avançada pode ter implicação nas queixas de dor dos pacientes com dor crônica crânio-facial...

The aims of this study was to assess the implications of advanced periodontal disease (PD), and the expression of NOS and sP of inflamed gingival tissue, in the intensity of pain and the quality of life in patients with chronic craniofacial pain. Were evaluated and treated 20 patients with complaints of chronic craniofacial pain and DP (Study Group), compared with 20 patients who had only DP (Control Group). After periodontal treatment there was reduction in the VAS and there was significant improvement of the initial complaints. In Study Group, there was significant reduction of pain affective descriptors and the scores of quality of life of this group were lower than the Control Group in the psychological and physical. The nNOS and iNOS expressions were higher in inflamed gingival Study Group and the expression of sP was similar in the two groups The data of this study show that advanced periodontal disease can have involvement in complaints of pain in patients with chronic craniofacial pain...